======= RGS2 ======= == Gene Information == * **Official Symbol**: RGS2 * **Official Name**: regulator of G protein signaling 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5997|5997]] * **UniProt**: [[https://www.uniprot.org/uniprot/P41220|P41220]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RGS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RGS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600861|Open OMIM]] == Function Summary == * **Entrez Summary**: Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 2 belongs to this family. The protein acts as a mediator of myeloid differentiation and may play a role in leukemogenesis. [provided by RefSeq, Aug 2009]. * **UniProt Summary**: Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:11063746, PubMed:19478087). It is involved in the negative regulation of the angiotensin-activated signaling pathway (PubMed:28784619). Plays a role in the regulation of blood pressure in response to signaling via G protein-coupled receptors and GNAQ. Plays a role in regulating the constriction and relaxation of vascular smooth muscle (By similarity). Binds EIF2B5 and blocks its activity, thereby inhibiting the translation of mRNA into protein (PubMed:19736320). {ECO:0000250|UniProtKB:O08849, ECO:0000269|PubMed:11063746, ECO:0000269|PubMed:11278586, ECO:0000269|PubMed:17901199, ECO:0000269|PubMed:19736320, ECO:0000269|PubMed:28784619, ECO:0000305|PubMed:7643615}. |RGS| |negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process| |regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process| |regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway| |negative regulation of glycine import across plasma membrane| |regulation of glycine import across plasma membrane| |negative regulation of neurotransmitter uptake| |relaxation of vascular smooth muscle| |regulation of amino acid import across plasma membrane| |regulation of amino acid transmembrane transport| |negative regulation of phospholipase activity| |relaxation of smooth muscle| |negative regulation of cell growth involved in cardiac muscle cell development| |negative regulation of amino acid transport| |positive regulation of cardiac muscle contraction| |relaxation of cardiac muscle| |positive regulation of striated muscle contraction| |negative regulation of smooth muscle contraction| |negative regulation of anion transmembrane transport| |negative regulation of cardiac muscle cell differentiation| |negative regulation of lipase activity| |regulation of cell growth involved in cardiac muscle cell development| |ovulation| |regulation of neurotransmitter uptake| |negative regulation of organic acid transport| |negative regulation of cardiocyte differentiation| |relaxation of muscle| |negative regulation of cAMP-mediated signaling| |negative regulation of cardiac muscle tissue growth| |negative regulation of muscle contraction| |negative regulation of neurotransmitter transport| |negative regulation of heart growth| |G-protein alpha-subunit binding| |negative regulation of amine transport| |negative regulation of cardiac muscle hypertrophy| |regulation of anion transmembrane transport| |brown fat cell differentiation| |negative regulation of anion transport| |negative regulation of muscle hypertrophy| |negative regulation of response to drug| |vasodilation| |regulation of amino acid transport| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |response to amphetamine| |regulation of cardiac muscle cell differentiation| |beta-tubulin binding| |positive regulation of heart contraction| |negative regulation of striated muscle cell differentiation| |positive regulation of muscle contraction| |response to amine| |negative regulation of G protein-coupled receptor signaling pathway| |negative regulation of striated muscle tissue development| |negative regulation of muscle organ development| |regulation of cAMP-mediated signaling| |regulation of cardiocyte differentiation| |negative regulation of muscle tissue development| |response to bronchodilator| |cytoplasmic side of plasma membrane| |negative regulation of muscle cell differentiation| |regulation of cardiac muscle hypertrophy| |positive regulation of blood vessel diameter| |regulation of organic acid transport| |regulation of cardiac muscle tissue growth| |regulation of muscle hypertrophy| |regulation of smooth muscle contraction| |regulation of heart growth| |maternal process involved in female pregnancy| |positive regulation of blood circulation| |regulation of phospholipase activity| |negative regulation of MAP kinase activity| |regulation of cardiac muscle contraction| |regulation of cardiac muscle tissue development| |negative regulation of cation transmembrane transport| |regulation of muscle adaptation| |regulation of striated muscle contraction| |regulation of amine transport| |regulation of organ growth| |negative regulation of ion transmembrane transport| |regulation of anion transport| |regulation of lipase activity| |regulation of response to drug| |regulation of striated muscle cell differentiation| |negative regulation of developmental growth| |fat cell differentiation| |negative regulation of transmembrane transport| |response to ethanol| |negative regulation of translation| |female gamete generation| |regulation of striated muscle tissue development| |negative regulation of protein serine/threonine kinase activity| |regulation of muscle tissue development| |regulation of muscle organ development| |regulation of tube diameter| |regulation of blood vessel diameter| |regulation of tube size| |regulation of neurotransmitter transport| |regulation of G protein-coupled receptor signaling pathway| |negative regulation of cellular amide metabolic process| |negative regulation of ion transport| |regulation of muscle cell differentiation| |regulation of muscle contraction| |negative regulation of MAPK cascade| |vascular process in circulatory system| |female pregnancy| |negative regulation of cell growth| |calmodulin binding| |multi-multicellular organism process| |negative regulation of protein kinase activity| |response to alcohol| |regulation of muscle system process| |regulation of heart contraction| |negative regulation of growth| |negative regulation of kinase activity| |negative regulation of transferase activity| |positive regulation of neuron projection development| |GTPase activator activity| |regulation of blood circulation| |muscle system process| |response to xenobiotic stimulus| |response to antibiotic| |neuron projection| |regulation of developmental growth| |GTPase activity| |negative regulation of cell development| |regulation of cation transmembrane transport| |regulation of MAP kinase activity| |regulation of neurotransmitter levels| |regulation of translation| |positive regulation of neuron differentiation| |positive regulation of cell projection organization| |blood circulation| |circulatory system process| |regulation of cellular amide metabolic process| |negative regulation of protein phosphorylation| |positive regulation of GTPase activity| |regulation of cell growth| |negative regulation of phosphorylation| |negative regulation of hydrolase activity| |positive regulation of neurogenesis| |regulation of ion transmembrane transport| |regulation of GTPase activity| |negative regulation of transport| |regulation of neuron projection development| |negative regulation of intracellular signal transduction| |response to toxic substance| |regulation of anatomical structure size| |regulation of protein serine/threonine kinase activity| |posttranscriptional regulation of gene expression| |positive regulation of nervous system development| |positive regulation of cell development| |spermatogenesis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |regulation of transmembrane transport| |male gamete generation| |regulation of system process| |negative regulation of protein modification process| |regulation of neuron differentiation| |regulation of growth| |gamete generation| |regulation of plasma membrane bounded cell projection organization| |regulation of ion transport| |regulation of cell projection organization| |negative regulation of cell differentiation| |brain development| |regulation of MAPK cascade| |positive regulation of hydrolase activity| |head development| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of neurogenesis| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |nucleolus| |regulation of kinase activity| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |positive regulation of cell differentiation| |regulation of transferase activity| |central nervous system development| |multi-organism reproductive process| |response to organonitrogen compound| |response to drug| |negative regulation of cellular protein metabolic process| |response to nitrogen compound| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |mitochondrion| |negative regulation of signal transduction| |regulation of hydrolase activity| |G protein-coupled receptor signaling pathway| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |generation of neurons| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of phosphorylation| |negative regulation of response to stimulus| |neurogenesis| |negative regulation of gene expression| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18833 * **Expression level (log2 read counts)**: 1.43 {{:chemogenomics:nalm6 dist.png?nolink |}}